GT307 Injection

autologous tumor-infiltrating lymphocytes · Grit Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GT307 Injection, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours [NA]